https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MC.jpg

Port Needles Market Analysis | China | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: China
  • Pages: 361
  • Published Date: 2/1/2017
  • Type: MedCore

The Chinese market for port needles increased moderately over the previous year. Growth in this market is due to increases in unit sales for both conventional and safety port needle devices that have been only slightly counteracted by decreases in the ASP. Unit sales for port needles are expected to decline in Chinese over the forecast period due to intense competition from local competitors as well as from low-cost producers in India and Korea.

The total Chinese market for port needles can be segmented by conventional and safety port needles. In 2016, the largest segment in the total port needle market was the conventional port needles, which accounted for a majority of the total market value. However, safety port needles are growing at a much faster pace than conventional port needles.

Segments Covered in This Market

  • Conventional Port Needle Market
  • Safety Safety Port Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

C. R. Bard was the leading competitor in the Chinese port needle market. B. Braun sells the Surecan® safety port needle and has been able to utilize their passive safety technology from the Introcan® peripheral intravenous catheter (PIVC). Smiths Medical sells GRIPPER PLUS® safety port needles, as well as conventional GRIPPER™ port needles and GRIPPER® POWER P.A.C. power-injectable safety port needles. Other companies include Terumo and Nipro.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled China Market Report Suite for Vascular Access Devices and Accessories – MedSuite

Learn More about these product types

TABLE OF CONTENTS I
LIST OF FIGURES XVI
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
CHINA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
MARKETS INCLUDED 7
KEY REPORT UPDATES 8
VERSION HISTORY 8
RESEARCH METHODOLOGY 9
1.1 RESEARCH SCOPE 9
1.2 IDATA’S 9-STEP METHODOLOGY 9
1.2.1 Step 1: Project Initiation & Team Selection 9
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 11
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design 12
1.2.4 Step 4: Performing Primary Research 13
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 15
1.2.6 Step 6: Market Forecast and Analysis 16
1.2.7 Step 7: Identify Strategic Opportunities 18
1.2.8 Step 8: Final Review and Market Release 19
1.2.9 Step 9: Customer Feedback and Market Monitoring 20
DISEASE OVERVIEW 21
2.1 BASIC ANATOMY 21
2.1.1 Human Vascular System 21
2.2 VASCULAR PATHOLOGY AND DISORDERS 22
2.2.1 Cancer 22
2.2.2 End-Stage Renal Disease 23
2.2.3 Diabetes 25
PRODUCT ASSESSMENT 28
3.1 PRODUCT PORTFOLIOS 28
3.1.1 Port Needles 28
3.1.1.1 Introduction 28
3.1.1.2 AngioDynamics 29
3.1.1.2.1 LifeGuard® 29
3.1.1.2.2 LifePort® 29
3.1.1.3 B. Braun 29
3.1.1.3.1 WHIN® 29
3.1.1.4 Cook Medical 29
3.1.1.4.1 Vital-Ject™ 29
3.1.1.5 C. R. Bard 29
3.1.1.5.1 PowerLoc® 29
3.1.1.5.2 Other Port Needle Offerings 30
3.1.1.6 Kawasumi 30
3.1.1.6.1 K-Shield® 30
3.1.1.6.2 Other Port Needle Offerings 30
3.1.1.7 MPS Medical, Inc. 30
3.1.1.7.1 SmartSafety® 30
3.1.1.8 Nipro Medical 30
3.1.1.8.1 SafeTouch™ 30
3.1.1.9 Smiths Medical 31
3.1.1.9.1 GRIPPER® 31
3.1.1.9.2 GRIPPER PLUS® 31
3.1.1.9.3 Other Port Needle Offerings 31
3.1.1.10 Vygon (Churchill Medical Systems) 31
3.1.1.10.1 LifeGuard™ 31
3.1.1.10.2 Wing Safe™ 31
3.2 REGULATORY ISSUES AND RECALLS 32
3.2.1 November 2015 32
3.2.2 October 2015 32
3.2.3 September 2015 33
3.2.4 August 2015 35
3.2.5 July 2015 36
3.2.6 April 2015 38
3.2.7 March 2015 39
3.2.8 February 2015 40
3.2.9 January 2015 40
3.2.10 December 2014 41
3.2.11 October 2014 42
3.2.12 September 2014 43
3.2.13 May 2014 44
3.2.14 April 2014 44
3.2.15 March 2014 45
3.2.16 January 2014 45
3.2.17 December 2013 46
3.2.18 September 2013 47
3.2.19 August 2013 48
3.2.20 June 2013 48
3.2.21 March 2013 49
3.2.22 February 2013 50
3.2.23 December 2012 50
3.2.24 August 2012 50
3.2.25 June 2012 51
3.2.26 May 2012 52
3.2.27 March 2012 53
3.2.28 February 2012 54
3.2.29 January 2012 54
3.3 PRODUCT PIPELINES 58
3.3.1 Alliance Vascular Devices, LLC 58
3.3.1.1 FreeHand Safety Huber Needle® 58
3.3.2 AngioDynamics 58
3.3.2.1 Celerity™ PICC Tip Confirmation System with Navigation 58
3.3.2.2 Firefly 58
3.3.2.3 BioFlo® PICC Line Extension 59
3.3.2.4 BioFlo® Port Line Extension 59
3.3.2.5 Next Generation BioFlo® PICC 59
3.3.2.6 Next Generation BioFlo® Port 59
3.3.3 Bluegrass Vascular Technologies, Inc. 59
3.3.3.1 Surfacer® Inside-Out™ Access System 59
3.3.4 C.R. Bard 59
3.3.4.1 Chemical-Resistant PICCs 59
3.3.4.2 Novel Advanced Material PICCs 60
3.3.4.3 PowerGlide® Pro Midline 60
3.3.4.4 AccuCath® 60
3.3.4.5 Xenesis™ Acute Hemodialysis Catheter 60
3.3.4.6 Site~Rite® 8 Ultrasound System 60
3.3.5 M. C. Johnson 60
3.3.5.1 PICC Securement Device 60
3.3.6 Nipro Medical 61
3.3.6.1 Shielding Safety Needle 61
3.3.6.2 Safety Syringe 61
3.3.6.3 Safety PIVC 61
3.3.7 Parasol Medical 61
3.3.7.1 Catheter Securement Device 61
3.3.8 PAVmed Inc. 61
3.3.8.1 NextCath™ 61
3.3.9 Phase One Medical 61
3.3.9.1 Goldilocks™ Long Term Hemodialysis Catheter 61
3.3.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter 62
3.3.10 Prodigy Diabetes Care, LLC. 62
3.3.10.1 Insulin Pen Needles 62
3.3.11 Sharklet Technologies, Inc. 62
3.3.11.1 Sharklet™ Central Venous Catheter 62
3.3.12 Starboard Medical 62
3.3.12.1 Catheter Securement Devices 62
3.3.13 Teleflex Medical 63
3.3.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System 63
3.3.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports 63
3.3.14 Vascular Access Technologies, Inc. 63
3.3.14.1 SAFECVAD™ 63
PORT NEEDLE MARKET 64
4.1 MARKET OVERVIEW 64
4.2 MARKET ANALYSIS AND FORECAST 68
4.2.1 Total Port Needle Market 68
4.2.2 Conventional Implantable Port Market 70
4.2.3 Power-Injectable Port Needle Market 72
4.3 DRIVERS AND LIMITERS 74
4.3.1 Market Drivers 74
4.3.2 Market Limiters 75
4.4 COMPETITIVE MARKET SHARE ANALYSIS 77
ABBREVIATIONS 80
APPENDIX: COMPANY PRESS RELEASES 81
The "China Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite" includes analysis on the following companies currently active in this market:
CR Bard
Teleflex
BD
B Braun
Smiths Medical
Medtronic
Cook Medical
Others include: Changzhou Yuandong Medical, Henan Concerone Industry Co., Heze Sinorgmed Polymers Co., Jiangsu Province Huaxing Medical, Jiangxi Sanxin Medtec Co., Lepu Medical Technology, Longreal Medevice Limited, Melson Medical Corporation Limited, Nanjing Hoshin Medical Instrument Co., Ningbo Win-Win Medical Instruments, Poweam Medical, Qingdao Joyjun Medical Products Co, Qingdao Medical Import & Export Co., Shandong Sinorgmed Co., Ltd., Shanghai Hengxin Medical Devices, Shanghai Madicare Co., Zibo Eastmed Healthcare Products, etc
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
Chart 1 1: Vascular Access Device and Accessories Market by Segment China, 2013 – 2023 2
Chart 1 2: Vascular Access Device and Accessories Market China, 2016 & 2023 2
Chart 4 1: Port Needle Market by Segment, China, 2013 – 2023 66
Chart 4 2: Port Needle Market Breakdown, China, 2016 67
Chart 4 3: Port Needle Market Breakdown, China, 2023 67
Chart 4 4: Total Port Needle Market, China, 2013 – 2023 69
Chart 4 5: Conventional Port Needle Market, China, 2013 – 2023 71
Chart 4 6: Power-Injectable Port Needle Market, China, 2013 – 2023 73
Chart 4 7: Leading Competitors, Port Needle Market, China, 2016 79

Figure 1 1: Leading Competitors by Segment, Vascular Access Device and Accessories Market, China, 2016 (1 of 2) 3
Figure 1 2: Leading Competitors by Segment, Vascular Access Device and Accessories Market, China, 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, China, 2016 4
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market, China 5
Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, China, 2012 – 2016 6
Figure 1 6: Vascular Access Device and Accessories Markets Covered, China, 2016 7
Figure 1 7: Key Report Updates 8
Figure 1 8: Version History 8
Figure 3 1: Class 2 Device Recall Medtronic 32
Figure 3 2: Class 2 Device Recall Smiths Medical 32
Figure 3 3: Class 2 Device Recall Arrow 33
Figure 3 4: Class 2 Device Recall Arrow 33
Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 34
Figure 3 6: Class 2 Device Recall Arrow 35
Figure 3 7: Class 2 Device Recall Medline 35
Figure 3 8: Class 2 Device Recall Arrow 35
Figure 3 9: Class 2 Device Recall B. Braun 35
Figure 3 10: Class 3 Device Recall Bard Access 36
Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 36
Figure 3 12: Class 2 Device Recall Bard Access 38
Figure 3 13: Class 2 Device Recall Bard Access 38
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 39
Figure 3 15: Class 2 Device Recall Bard Access 39
Figure 3 16: Class 2 Device Recall Arrow 40
Figure 3 17: Class 2 Device Recall Medcomp 40
Figure 3 18: Class 2 Device Recall Arrow 40
Figure 3 19: Class 2 Device Recall Arrow 41
Figure 3 20: Class 2 Device Recall Smiths Medical 41
Figure 3 21: Class 2 Device Recall PFM Medical 41
Figure 3 22: Class 2 Device Recall PFM Medical 41
Figure 3 23: Class 2 Device Recall Becton Dickinson 42
Figure 3 24: Class 2 Device Recall Arrow 42
Figure 3 25: Class 2 Device Recall Arrow 42
Figure 3 26: Class 2 Device Recall Navilyst Medical 42
Figure 3 27: Class 2 Device Recall Argon Medical 43
Figure 3 28: Class 2 Device Recall Arrow 44
Figure 3 29: Class 2 Device Recall Arrow 44
Figure 3 30: Class 2 Device Recall Arrow 45
Figure 3 31: Class 2 Device Recall Bard Access 45
Figure 3 32: Class 2 Device Recall Navilyst Medical 45
Figure 3 33: Class 2 Device Recall Bard Access 46
Figure 3 34: Class 2 Device Recall Smiths Medical 46
Figure 3 35: Class 2 Device Recall B. Braun 46
Figure 3 36: Class 2 Device Recall Smiths Medical 47
Figure 3 37: Class 2 Device Recall Access Scientific 47
Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 47
Figure 3 39: Class 2 Device Recall Arrow 48
Figure 3 40: Class 2 Device Recall Bard Access 48
Figure 3 41: Class 2 Device Recall Becton Dickinson 48
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 49
Figure 3 43: Class 2 Device Recall Bard Access 49
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 49
Figure 3 45: Class 2 Device Recall Medcomp 50
Figure 3 46: Class 2 Device Recall Becton Dickinson 50
Figure 3 47: Class 3 Device Recall Bard Access 50
Figure 3 48: Class 2 Device Recall Medcomp 51
Figure 3 49: Class 1 Device Recall Arrow 51
Figure 3 50: Class 2 Device Recall Arrow 51
Figure 3 51: Class 2 Device Recall Vygon 51
Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 52
Figure 3 53: Class 2 Device Recall Medcomp 53
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 53
Figure 3 55: Class 2 Device Recall Christie Medical Holdings 53
Figure 3 56: Class 3 Recall Bard Access 53
Figure 3 57: Class 2 Device Recall AngioDynamics 54
Figure 3 58: Class 2 Device Recall Becton Dickinson 54
Figure 3 59: Class 2 Device Recall AngioDynamics 54
Figure 3 60: Class 2 Device Recall AngioDynamics 56
Figure 3 61: Class 3 Device Recall AngioDynamics 57
Figure 3 62: Class 2 Device Recall AngioDynamics 57
Figure 4 1: Port Needle Market by Segment, China, 2013 – 2023 (U$M) 64
Figure 4 2: Port Needle Market by Segment, China, 2013 – 2023 (CN¥M) 65
Figure 4 3: Total Port Needle Market, China, 2013 – 2023 68
Figure 4 4: Conventional Port Needle Market, China, 2013 – 2023 70
Figure 4 5: Power-Injectable Port Needle Market, China, 2013 – 2023 72
Figure 4 6: Drivers and Limiters, Port Needle Market, China, 2016 76
Figure 4 7: Leading Competitors, Port Needle Market, China, 2016 78
Figure 6 1: Press Release Summary 81

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology